Back to Search
Start Over
Response to the novel corona virus (COVID-19) pandemic across Africa: successes, challenges, and implications for the future
- Source :
- Frontiers in Pharmacology, Vol 11 (2020), Frontiers in Pharmacology, FRONTIERS IN PHARMACOLOGY
- Publication Year :
- 2020
-
Abstract
- Background The COVID-19 pandemic has already claimed considerable lives. There are major concerns in Africa due to existing high prevalence rates for both infectious and non-infectious diseases and limited resources in terms of personnel, beds and equipment. Alongside this, concerns that lockdown and other measures will have on prevention and management of other infectious diseases and non-communicable diseases (NCDs). NCDs are an increasing issue with rising morbidity and mortality rates. The World Health Organization (WHO) warns that a lack of nets and treatment could result in up to 18 million additional cases of malaria and up to 30,000 additional deaths in sub-Saharan Africa. Objective Document current prevalence and mortality rates from COVID-19 alongside economic and other measures to reduce its spread and impact across Africa. In addition, suggested ways forward among all key stakeholder groups. Our approach Contextualise the findings from a wide range of publications including internet-based publications coupled with input from senior-level personnel. Ongoing activities Prevalence and mortality rates are currently lower in Africa than among several Western countries and the USA. This could be due to a number of factors including early instigation of lockdown and border closures, the younger age of the population, lack of robust reporting systems and as yet unidentified genetic and other factors. Innovation is accelerating to address concerns with available equipment. There are ongoing steps to address the level of misinformation and its consequences including fines. There are also ongoing initiatives across Africa to start addressing the unintended consequences of COVID-19 activities including lockdown measures and their impact on NCDs including the likely rise in mental health disorders, exacerbated by increasing stigma associated with COVID-19. Strategies include extending prescription lengths, telemedicine and encouraging vaccination. However, these need to be accelerated to prevent increased morbidity and mortality. Conclusion There are multiple activities across Africa to reduce the spread of COVID-19 and address misinformation, which can have catastrophic consequences, assisted by the WHO and others, which appear to be working in a number of countries. Research is ongoing to clarify the unintended consequences given ongoing concerns to guide future activities. Countries are learning from each other.
- Subjects :
- 0301 basic medicine
RM
Population
prevalence
review
03 medical and health sciences
0302 clinical medicine
Political science
Development economics
Pandemic
Pharmacology (medical)
Misinformation
education
misinformation
Health policy
Pharmacology
education.field_of_study
treatment
Unintended consequences
Mortality rate
lcsh:RM1-950
unintended consequences
Stakeholder
COVID-19
health policy
Mental health
3. Good health
030104 developmental biology
lcsh:Therapeutics. Pharmacology
030220 oncology & carcinogenesis
Africa
Subjects
Details
- Language :
- English
- ISSN :
- 16639812
- Database :
- OpenAIRE
- Journal :
- Frontiers in Pharmacology, Vol 11 (2020), Frontiers in Pharmacology, FRONTIERS IN PHARMACOLOGY
- Accession number :
- edsair.doi.dedup.....d7ea906ba85b0bceca5220d655649d0e